HomeNDC LookupIngredients › Mirvetuximab Soravtansine Gynx
📦 NDC / package directory — not a drug information page

Mirvetuximab Soravtansine Gynx NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Mirvetuximab Soravtansine Gynx products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

1
Package NDCs
1
Products
1
Active listings
0
Discontinued
1
Labelers
1
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
MIRVETUXIMAB SORAVTANSINE-GYNX 100... 1
By dosage form
INJECTION 1
Top labelers
BSP Pharmaceuticals S.p.A. 1

Browse records — 1 product

Drug / product Billing NDC NADAC / unit Status
mirvetuximab soravtansine gynx 100 mg/20mL INJECTION BSP · NDC 43624-0012-01 · 4 TRAY in 1 BOX (43624-012-01) / 81 VIAL, SINGLE-DOSE in 1 TRAY / 20 mL in 1 VIAL, SINGLE-DOSE 43624-0012-01 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.